NDC 70515-604

Zanaflex

Tizanidine Hydrochloride

Zanaflex is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Covis Pharma Us, Inc. The primary component is Tizanidine Hydrochloride.

Product ID70515-604_4caebc2e-bf10-442a-b24d-c3b51876c67f
NDC70515-604
Product TypeHuman Prescription Drug
Proprietary NameZanaflex
Generic NameTizanidine Hydrochloride
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2018-08-01
Marketing CategoryNDA / NDA
Application NumberNDA021447
Labeler NameCovis Pharma US, Inc
Substance NameTIZANIDINE HYDROCHLORIDE
Active Ingredient Strength4 mg/1
Pharm ClassesAdrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70515-604-15

150 CAPSULE in 1 BOTTLE (70515-604-15)
Marketing Start Date2018-08-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70515-604-15 [70515060415]

Zanaflex CAPSULE
Marketing CategoryNDA
Application NumberNDA021447
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-08-01

Drug Details

Active Ingredients

IngredientStrength
TIZANIDINE HYDROCHLORIDE4 mg/1

OpenFDA Data

SPL SET ID:043d9e51-bfa2-4add-9058-5ece332f7e99
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 583211
  • 583165
  • 580267
  • 313413
  • 485485
  • 485484
  • 153735
  • 485486
    • UPC Code
  • 0370515602151
  • 0370515594159
  • 0370515606159

    • Pharmacological Class

    • Adrenergic alpha2-Agonists [MoA]
    • Central alpha-2 Adrenergic Agonist [EPC]
    • Adrenergic alpha2-Agonists [MoA]
    • Central alpha-2 Adrenergic Agonist [EPC]

    NDC Crossover Matching brand name "Zanaflex" or generic name "Tizanidine Hydrochloride"

    NDCBrand NameGeneric Name
    10144-594Zanaflextizanidine hydrochloride
    10144-602Zanaflextizanidine hydrochloride
    10144-604Zanaflextizanidine hydrochloride
    10144-606Zanaflextizanidine hydrochloride
    21695-373Zanaflextizanidine hydrochloride
    70515-594ZanaflexZanaflex
    70515-604ZanaflexZanaflex
    70515-602ZanaflexZanaflex
    70515-606ZanaflexZanaflex
    55289-612ZanaflexZanaflex
    80425-0022ZanaflexZanaflex
    80425-0024ZanaflexZanaflex
    80425-0090ZanaflexZanaflex
    80425-0023ZanaflexZanaflex
    0185-0034tizanidine hydrochloridetizanidine hydrochloride
    0185-4400tizanidine hydrochloridetizanidine hydrochloride
    0591-2788tizanidine hydrochloridetizanidine hydrochloride
    0591-2789tizanidine hydrochloridetizanidine hydrochloride
    0591-2790tizanidine hydrochloridetizanidine hydrochloride
    21695-126TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE
    21695-127TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE
    35356-662TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE
    42291-810Tizanidine HydrochlorideTizanidine Hydrochloride
    42291-811Tizanidine HydrochlorideTizanidine Hydrochloride
    42291-812Tizanidine HydrochlorideTizanidine Hydrochloride
    45865-954Tizanidine HydrochlorideTizanidine Hydrochloride
    46708-491Tizanidine HydrochlorideTizanidine Hydrochloride
    46708-492Tizanidine HydrochlorideTizanidine Hydrochloride
    46708-493Tizanidine HydrochlorideTizanidine Hydrochloride
    49884-611tizanidine hydrochloridetizanidine hydrochloride
    49884-719tizanidine hydrochloridetizanidine hydrochloride
    49884-765tizanidine hydrochloridetizanidine hydrochloride
    49999-347Tizanidine HydrochlorideTizanidine Hydrochloride

    Trademark Results [Zanaflex]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZANAFLEX
    ZANAFLEX
    75186534 2383531 Live/Registered
    COVIS PHARMA B.V.
    1996-10-15
    ZANAFLEX
    ZANAFLEX
    74400930 1906277 Dead/Cancelled
    ELAN PHARMACEUTICALS, INC.
    1993-06-09
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.